Author

Tanja Mehlo-Jensen

Bristol-Myers Squibb (United States)ORCID 0009-0001-9541-2803Unclaimed ORCID profile · follow to get notified of new preprints

Biology Disciplines

Click to filter author papers

Immunology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Research Focus:cancer & tumor microenvironment· 1 Approach:genetic perturbation / CRISPR· 1 Organism:mouse· 1

Frequent Co-Authors

Axel RoersiD· 1 shared C. Mark HilliD· 1 shared Christine TuniD· 1 shared Elif Doğan DariD· 1 shared Emilija MarinkovićiD· 1 shared Jack LohreiD· 1 shared Janet Y. LeungiD· 1 shared Jennifer M. SahniiD· 1 shared

Activity by Year

2025-2025 · peak 1/yr

Co-Author Collaboration Network

10 top collaborators · 45 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperImmunology

Axel RoersORCID

Mutual co-authors in cluster

Author profile →

1 paper

Recent·Most cited

ImmunologyCancer ResearchPeer-reviewedMay 12, 2025

Selective inflammation of the tumor microenvironment and invigorated T cell-mediated tumor control upon induced systemic inactivation of TREX1

Emilija Marinković, Minyi Chen, Nadja Schubert…·Axel Roers

This study shows that systemic TREX1 inhibition enhances anti-tumor immunity by increasing T cell infiltration and activity in tumors while sparing other tissues.

11 citations

mousegenetic perturbation / CRISPR